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Abstract
Low vitamin D status may be associated with depression. Few studies have examined vitamin D and depression in older adults living at northern latitudes.
The present study cross-sectionally investigated serum 25-hydroxyvitamin D (25(OH)D) status and depression among 5006 community-dwelling older
persons (66–96 years) living in Iceland (latitudes 64–66°N). Depressive symptoms were measured by the ﬁfteen-item Geriatric Depression Scale
(GDS-15). Current major depressive disorder was assessed according to Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV)
criteria. Serum 25(OH)D was analysed using chemiluminescence immunoassay and categorised into three groups: deﬁcient (<30 nmol/l); inadequate
(30–49·9 nmol/l); and adequate (≥50 nmol/l). There were twenty-eight (2 %) men and ﬁfty (1 %) women with current major depressive disorder.
Mean GDS-15 scores for men and women with adequate vitamin D concentrations were 2·1 and 2·2, respectively. Men and women with deﬁcient v.
adequate vitamin D status had more depressive symptoms (higher GDS-15 scores) (difference 0·7 (95 % CI 0·4, 0·9) and 0·4 (95 % CI 0·1, 0·6), respect-
ively). Furthermore, men with deﬁcient vitamin D status were more likely to have current major depressive disorder (adjusted OR 2·51; 95 % CI 1·03, 6·13)
compared with men with adequate vitamin D status. Associations among women were not signiﬁcant. In this older population living at northern latitudes,
deﬁcient vitamin D status may be associated with depression. Further investigations are warranted to evaluate the pathways that may be associated with risk
of depression among older adults.
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Depression is one of the most common mental disorders and
is recognised as a major contributor to the global burden of
disease(1,2). Individuals of advanced age, in particular, may
be prone to developing depression due to life changes such
as chronic illness, moving into a retirement facility, and loss
of a spouse or close friends(3). Depressive symptoms are
prevalent in approximately 15 % of community-dwelling
older persons(4), with major depressive disorder prevalent in
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1–5 % of adults 65 years and older(5). However, a more recent
systematic review estimated the prevalence of major depres-
sion in late life (>75 years) to range from 4·6 to 9·3 %(6), sug-
gesting it may be an increasing problem in old age. Depression
risk among older adults may be further exacerbated by an
interaction of factors beyond age such as poor dietary intake
and time spent indoors which can negatively affect vitamin
D status(7).
The inﬂuence of vitamin D on the risk of depression has
gathered attention due to the identiﬁcation of vitamin D recep-
tors in locations of the brain linked to depression(8).
Associations between serum 25-hydroxyvitamin D (25(OH)D)
levels and depressive symptoms have primarily been investi-
gated in observational studies and ﬁndings have been inconsist-
ent(9–16). A meta-analysis of cross-sectional studies reported a
non-signiﬁcant but increased risk of depression with vitamin
D status below v. above 50 nmol/l (hazard ratio 1·31; 95 %
CI 1·00, 1·71); limiting the analyses to participants aged 65
years and older did not change the risk estimates(17).
Few studies have investigated vitamin D status and depres-
sion in older adults living at northern latitudes. In Iceland,
where the latitude reaches from 64–66°N, dermal production
of vitamin D is limited from October to April(18). Therefore,
intake of a vitamin D-containing supplement is recommended,
and cod liver oil has been a traditional component of the Icelandic
diet for many decades(19). The aim of this present study was to
investigate associations between vitamin D status measured by
serum 25(OH)D concentrations and depression in older adults
with data on health and lifestyle factors, and where a combination
of cod liver oil intake and unique geographical location results in
large variations in serum vitamin D levels.
Experimental methods
Study population
This is a cross-sectional analysis of the Age, Gene/
Environment Susceptibility–Reykjavik (AGES-Reykjavik) Study;
a continuation of the population-based Reykjavik Study initiated
by the Icelandic Heart Association(20). Participants were 5764
older men and women, of mean age 77·0 (SD 5·9) years, living
in the greater Reykjavik area who were randomly chosen from
survivors who were enrolled in the Reykjavik Study and who
agreed to participate in the AGES-Reykjavik Study. Detailed
data on medical and lifestyle history were collected. The
Mini-International Neuropsychiatric Interview (MINI) was
used to assess psychiatric disorders, including major depressive
disorder. Participants who exhibited cognitive impairment by
scoring <21 on the Mini-Mental State Examination (MMSE)
or who were unable to complete theMMSE (n 396) were not eli-
gible to take the MINI and were thus excluded from this ana-
lysis. Furthermore, individuals with missing serum 25(OH)D
levels (n 121) and covariates used in the statistical analyses
(n 241) were excluded, leaving 5006 (43 % males) individuals
in the current analysis.
The AGES-Reykjavik Study was approved by the Icelandic
National Bioethics Committee (VSN: 00-063) and the
MedStar IRB for the Intramural Research Program,
Baltimore, MD, USA. Informed written consent was obtained
from all participants.
Measurement of serum 25-hydroxyvitamin D
Fasting blood samples were collected between September 2002
and January 2006 and kept frozen at –80°C until analysis.
Measurement of total serum 25(OH)D, including both vita-
mins D2 and D3, was processed on-site at the Icelandic
Heart Association by means of a direct, competitive chemilu-
minescence immunoassay using the LIAISON 25 OH
Vitamin D total assay (Diasorin, Inc.), hereafter referred to
as vitamin D. The interassay CV was <6·5 % when using a
frozen serum pool as a control sample and <12·7 % when
using Liaison quality controls.
Cod liver oil intake
Information on intake of cod liver oil was gathered using a
FFQ designed for the AGES-Reykjavik Study. Participants
were asked how often they were taking cod liver oil currently
as well as when they were middle aged (40–50 years). The
response categories for cod liver oil intake were: never; less
than once per week; 1–2 times per week; 3–4 times per
week; 5–6 times per week; or daily. The cod liver oil intake
assessed by the FFQ has been shown to be well correlated
with quantities collected at midlife when compared with diet-
ary data collected as part of a national dietary survey and intake
in old age where the AGES FFQ was compared with 3-d
weighed food records completed by the same individuals
(Spearman’s ρ= 0·53 and 0·56, P< 0·001 for men and women,
respectively, at midlife and ρ= 0·51 and 0·42, P< 0·001 for
men and women, respectively, in old age)(21,22).
Depression
The protocol for diagnosing subjects with depression in the
AGES-Reykjavik Study has been previously described(23,24).
Major depressive disorder was assessed according to
Diagnostic and Statistical Manual of Mental Disorders, fourth
edition (DSM-IV) criteria using the MINI, a structured diag-
nostic test designed for epidemiological studies which provides
information about past and current (preceding 2 weeks)
depressive episodes. Participants completed the MINI if they
screened positive for depressive symptoms, i.e. ≥6 on the
ﬁfteen-item Geriatric Depression Scale (GDS-15), had occur-
rences of anxiety, were told by a doctor they had depression,
reported ever using antidepressant medications, or if they
were using antidepressant medications as evidenced from
medication bottles brought to the study interview. All partici-
pants completed the GDS-15 which provides self-reported
information on depressive symptoms in the preceding week
and has been validated in the Icelandic population(25).
Covariates
The following covariates were selected based on a potential
relationship with serum vitamin D status or depression and
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could confound the association between them. Age, education
(primary, secondary, college, or university), season of blood
draw (winter: December–February, spring: March–May, sum-
mer: June–August, autumn: September–November), BMI,
alcohol intake (<25, 25–50, ≥50 g/week), current smoking
(yes/no), marital status (single/divorced/widowed or mar-
ried/living together), current antidepressant use (yes/no),
physical activity (moderate to vigorous <0·05, 0·05–5·0, >5 h/
week), multivitamin use (yes/no), and leisure indoor activities
(d/month) were assessed by questionnaire or clinical assessment.
Diagnosis of type 2 diabetes was based on fasting serum glucose
of ≥7 mmol/l, self-reported doctor’s diagnosis, and/or use of
diabetes medication. Diagnosis of CHD was conﬁrmed by elec-
trocardiography and/or self-reported doctor’s diagnosis.
Hypertension was diagnosed by having physiological measure-
ments of systolic blood pressure ≥140 mm Hg and/or diastolic
blood pressure ≥90 mm Hg, self-reported doctor’s diagnosis
and/or use of hypertension medications.
Statistical analyses
Participant characteristics were described using mean and
standard deviation for normally distributed variables, median
and interquartile range for skewed variables or proportion
(%) for dichotomous variables. Men and women were ana-
lysed separately because of sex-speciﬁc differences in the
prevalence of depression(26). Vitamin D as determined by
25(OH)D concentrations was categorised into three groups:
deﬁcient (<30 nmol/l); inadequate (30–49·9 nmol/l); and
adequate (≥50 nmol/l) based on recommended levels in the
literature(27). For continuous variables, differences between
the three vitamin D categories were identiﬁed using one-way
ANOVA for normally distributed variables and the
Kruskal–Wallis test for non-normally distributed variables.
For dichotomous variables, differences between groups were
identiﬁed with the Pearson χ2 test.
The main outcome measures used were depressive symp-
toms based on the GDS-15 scores and current major depres-
sive disorder based on the MINI. Multivariate linear regression
analyses were used to assess the association between vitamin
D and GDS-15 scores. Analyses for GDS-15 scores were
adjusted for all covariates including antidepressant use. Since
the MINI takes into consideration antidepressant medication
use, antidepressant use was not adjusted for in the analyses
with current major depressive disorder. Logistic regression
analyses were used to estimate the OR and 95 % CI of current
major depressive disorder with adjustments for the covariates
previously described excluding antidepressant use. Adequate
vitamin D was the reference category. Analyses were per-
formed using SAS, version 9.2 (SAS Institute). Level of signiﬁ-
cance was set at P ≤ 0·05, two-sided.
Results
Overall, there were twenty-eight men (2 %) and ﬁfty (1 %)
women with current major depressive disorder. Half of the
women and 41 % of men in the cohort had deﬁcient or inad-
equate vitamin D levels. Tables 1 and 2 summarise the
participant characteristics by serum vitamin D level separately
for men and women. The prevalence of current major depres-
sive disorder was higher among men with deﬁcient (<30
nmol/l) v. adequate (≥50 nmol/l) serum vitamin D levels
(3 v. 1 %) but not among women (1 v. 2 %). Both men and
women with the lowest vitamin D levels were more likely to
have a higher BMI, smoke, live alone, consume less alcohol
and cod liver oil, not use multivitamins and were less likely
to be physically active compared with those with higher vita-
min D status. Women with lower vitamin D status were
more likely to use antidepressant medication. Higher GDS-15
scores (i.e. more depressive symptoms) were also observed in
both men and women with the lowest vitamin D categories.
Depression and vitamin D status
Mean GDS-15 scores were 2·1 (SD 1·8) and 2·2 (SD 2·0) for
men and women, respectively, with adequate 25(OH)D con-
centrations. Men and women with deﬁcient v. adequate vita-
min D status had higher GDS-15 scores (more depressive
symptoms) (difference 0·7 (95 % CI 0·4, 0·9) and 0·4 (95 %
CI 0·1, 0·6), respectively; Table 3). Findings remained largely
unchanged after further adjustment for cod liver oil intake.
Men who had deﬁcient vitamin D status were also more likely
to be currently depressed even after adjustments for age, sea-
son of blood draw and education (OR 3·60; 95 % CI 1·34,
6·95) (Table 4, model 1). The association among men attenu-
ated slightly after adjustments for lifestyle factors and chronic
diseases, but remained signiﬁcant after full multivariate adjust-
ment (OR 2·51; 95 % CI 1·03, 6·13) (Table 4, model 3).
Further adjustment for current cod liver oil intake did not
markedly change the OR for men (2·67; 95 % CI 1·02, 7·01).
There was no signiﬁcant association between vitamin D status
and depression in women.
As the presence of chronic disease may inﬂuence risk of
depression, we ran analyses excluding participants with chronic
disease (i.e. hypertension, CHD and diabetes) to determine
whether they were driving the association with depression.
The adjusted difference between vitamin D status (deﬁcient
v. adequate) and GDS-15 scores remained signiﬁcant (differ-
ence 1·7 (95 % CI 0·6, 2·8) and 0·7 (95 % CI 0·1, 1·4) for
men and women, respectively). Results for current major
depressive disorder and vitamin D were not signiﬁcant
among men and women with no chronic disease (combined
due to the low number of depression cases).
Discussion
In this older population-based cohort living at northern latitudes,
we found a modest inverse association between vitamin D status
and depressive symptoms among both men and women.
Furthermore, older men with deﬁcient serum vitamin D levels
(<30 nmol/l) were twice as likely to be currently depressed com-
paredwith comparably agedmenwith adequate vitaminD levels
(≥50 nmol/l) even after accounting for other factors such as
diabetes and hypertension which might confer a health-related
reason for depression. We found no association between
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vitamin D status and current major depressive disorder among
women.
Previous cross-sectional studies linking low serum 25(OH)D
levels with depressive symptoms have reported stronger
inverse associations among women compared with
men(10,16,28), while ﬁndings from the Concord Health and
Ageing in Men (CHAMP) study and European Male Ageing
Study (EMAS) reported signiﬁcant inverse associations
among men(12,29). Two large population-based studies in
China and the USA reported no association between depres-
sive symptoms and serum 25(OH)D levels but sex-speciﬁc
results were not provided(14,15). There have been varying
results from prospective studies. In a Italian study of older
adults, women with serum 25(OH)D levels below 50 nmol/l
were at greater risk of developing a depressed mood after 6
years (hazard ratio 2·09; 95 % CI 1·25, 3·49)(28). Another
study of elderly Chinese men reported an inverse association
between vitamin D status and depression at baseline but not
at follow-up 4 years later(30).
Physical activity, if performed outdoors, is important for
both dermal production of vitamin D and its potential to alle-
viate depressive symptoms(31). Less physical activity was asso-
ciated with reduced vitamin D levels and it modestly
attenuated the OR for depression when we adjusted for it in
our analyses. Individuals with depression also have a greater
likelihood of staying indoors and having poorer dietary habits,
thereby affecting vitamin D status(7). However, the frequency
of leisure indoor activities was not signiﬁcantly different
among the vitamin D categories in both men and women.
Season may also inﬂuence vitamin D levels and we found vita-
min D levels to be, on average, 5 nmol/l higher in the summer
months compared with the winter months for both men and
women (data not shown). However, we did not ﬁnd seasonal
differences on the association between vitamin D concentra-
tions and depression in our cohort. Reasons for these small
differences may be partially attributed to the northern latitude
and limited amount of sun exposure. During the summer
months in Iceland, people tend to still wear long sleeves and
trousers, and the high frequency of cod liver oil use through-
out the year may negate some seasonal variations.
The signiﬁcant relationship that we observed between vita-
min D status and depression among men is contrary to
prior cross-sectional reports where analyses were performed
separately by sex(10,16). There is some evidence that men
place more value on autonomy(32) and an increase in depend-
ency, particularly secondary to chronic diseases, has been asso-
ciated with depression(33). The presence of diabetes, in
particular, can double the odds of depression(34). The men
Table 1. Baseline characteristics of the men by serum 25-hydroxyvitamin D (25(OH)D) status
(Mean values and standard deviations, or percentages)
25(OH)D (nmol/l)
Deficient (<30)
(n 295)
Inadequate (30–49·9)
(n 574)
Adequate (≥50)
(n 1261)
Mean SD Mean SD Mean SD P
Characteristic
Age (years) 76·2 5·7 76·6 5·5 76·5 5·2 0·58
Height (cm) 175·4 6·2 175·2 6·2 175·8 6·1 0·16
Weight (kg) 83·9 14·8 84·3 13·8 82·2 12·8 0·0038
BMI (kg/m2) 27·2 4·3 27·4 3·9 26·6 3·6 <0·0001
Vitamin D (nmol/l)* 27·0 5·5 41·0 10·2 68·6 22·4 <0·0001
GDS-15 score 2·9 2·7 2·3 1·8 2·1 1·8 <0·0001
Current major depressive disorder (%) 3 1 1 0·002
Lifestyle
Education (%) 0·0117
Primary 17 18 13
Secondary 54 51 54
College 15 13 13
University 14 18 20
Current smoker (%) 22 12 9 <0·0001
Cod liver oil intake (%) <0·0001
<Once per week 61 38 16
1–6 times per week 11 15 9
Daily 28 47 75
Antidepressant use (%) 3 2 1 0·06
Multivitamin use (%) 15 21 30 <0·0001
Physical activity (h/week) 0·82 1·96 1·32 2·32 1·69 2·52 <0·0001
Alcohol (g/week)* 4·8 24·1 6·4 26·4 8·0 24·8 0·0098
Leisure activities (d/month) 4·5 3·4 4·6 3·7 4·6 3·5 0·83
Living with partner (%) 66 74 81 <0·0001
Chronic diseases
Type 2 diabetes (%) 20 17 13 0·0129
CHD (%) 38 33 32 0·18
Hypertension (%) 87 80 79 0·0084
GDS, Geriatric Depression Scale.
* Median and interquartile range.
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and women in our cohort with deﬁcient vitamin D status,
compared with higher levels, had the highest prevalence of
type 2 diabetes and other chronic diseases; however, adjust-
ment for these diseases in our analyses did not markedly
change the ﬁndings. Our sensitivity analyses excluding partici-
pants with chronic diseases also yielded signiﬁcant results. It is
possible that lifestyle changes were connected to depressive
status, although we were unable with the data available to dif-
ferentiate whether this might be the case. We did observe that
cod liver oil intake was inversely correlated with vitamin D sta-
tus, and the mean difference in serum 25(OH)D concentra-
tions between those with no v. daily intake was around 20
nmol/l. Further adjustments for current cod liver oil intake
in our analyses of vitamin D status and depression did not
change the signiﬁcant ﬁndings and other factors not accounted
for by cod liver oil intake are likely to be of importance.
However, as cod liver oil intake and vitamin D status are close-
ly connected, it is difﬁcult to separate completely the effects of
these two variables.
A possible explanation for the lack of association among
women with current major depressive disorder may be that
following menopause, the primary predictor of depression is
prior depressive history(35) although certain life events(3), as
previously stated, can affect depression risk. However, the
Table 3. Adjusted difference in fifteen-item Geriatric Depression Scale (GDS-15) score compared with men and women with adequate serum
25-hydroxyvitamin D (25(OH)D) status (≥50 nmol/l)
(Differences and 95 % confidence intervals)
Men Women
Serum 25(OH)D status (nmol/l) Difference*† 95 % CI Difference*† 95 % CI
Deficient (<30) 0·7 0·4, 0·9 0·4 0·1, 0·6
Inadequate (30–49·9) 0·1 −0·1, 0·3 −0·0 −0·2, 0·2
Adequate (≥50) Reference Reference
* Adjusted difference in GDS-15 score compared with adequate serum 25(OH)D.
† Adjusted for season, education, age, BMI, smoking, alcohol intake, antidepressant use, partner status, multivitamin use, physical activity, hypertension, CHD and diabetes.
Table 2. Baseline characteristics of the women by 25-hydroxyvitamin D (25(OH)D) status
(Mean values and standard deviations, or percentages)
25(OH)D (nmol/l)
Deficient (<30)
(n 536)
Inadequate (30–49·9)
(n 912)
Adequate (≥50)
(n 1428)
Mean SD Mean SD Mean SD P
Characteristic
Age (years) 76·4 5·5 76·4 5·7 76·1 5·5 0·47
Height (cm) 160·4 5·7 160·9 5·5 161·2 5·8 0·02
Weight (kg) 73·0 15·0 72·0 13·3 68·8 11·9 <0·0001
BMI (kg/m2) 28·3 5·4 27·8 4·8 26·5 4·3 <0·0001
Vitamin D (nmol/l)* 21·8 8·9 40·7 10·1 65·1 19·0 <0·0001
GDS-15 score 2·9 2·2 2·3 2·1 2·2 2·0 <0·0001
Current major depressive disorder (%) 1 2 2 0·14
Lifestyle
Education (%) <0·0001
Primary 35 28 26
Secondary 48 48 48
College 13 17 20
University 4 7 6
Current smoker (%) 20 13 11 <0·0001
Cod liver oil use (%) <0·0001
<Once per week 57 34 18
1–6 times per week 9 11 6
Daily 34 55 76
Antidepressant use (%) 7 4 5 0·03
Multivitamin use (%) 17 34 40 <0·0001
Physical activity (h/week) 0·60 1·61 1·01 1·99 1·21 2·15 <0·0001
Alcohol (g/week)* 1·6 3·2 1·6 8·0 1·6 13·2 <0·0001
Leisure activities (d/month) 5·2 3·5 5·1 3·4 5·4 3·5 0·16
Living with partner (%) 42 46 50 0·0020
Chronic diseases
Type 2 diabetes (%) 13 10 7 0·0003
CHD (%) 18 13 13 0·0140
Hypertension (%) 83 82 80 0·33
GDS, Geriatric Depression Scale.
* Median and interquartile range.
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inverse association with current depressive symptoms suggests
that vitamin D may still be an important nutrient with respect
to protection against pathways that could lead to depres-
sion(36). The sex-speciﬁc differences we observed suggest
that future studies should analyse men and women separately,
especially as our combined analyses of data on men and
women comparing deﬁciency v. adequate vitamin D status
yielded a null result (OR for current major depressive disorder
1·30; 95 % CI 0·75, 2·27).
Our ﬁndings in men and those from previous observational
studies(10,12,16,28,29) suggest that higher vitamin D levels may
potentially be associated with less depression. However,
reports from intervention studies have been mixed. Three
large randomised controlled trials found no association
between vitamin D supplementation and depression among
postmenopausal women(37–39). In a randomised controlled
trial in Norway, a high dose of vitamin D provided to men
and women aged 30–75 years with low (mean 40·1 nmol/l)
serum 25(OH)D levels for 6 months did not improve depres-
sion scores compared with controls who had taken a pla-
cebo(40). A separate Norwegian study reported positive effects
of vitamin D supplementation on reducing depressive symp-
toms among 441 overweight or obese individuals, although
few participants exhibited depressive symptoms at the
onset(41). The inconsistencies between the studies could be
attributed to variations in the participants’ baseline vitamin D sta-
tus, intake and sun exposure particularly at northern latitudes.
It is also possible that vitamin D deﬁciency (serum levels
<30 nmol/l) but not inadequacy (30–49·9 nmol/l) is asso-
ciated with depression. Researchers from the Australian
CHAMP study suggest that the optimal 25(OH)D range in
older men to be between 50 and 74·9 nmol/l(12). However,
in a country at more northern latitudes such as Iceland, main-
taining vitamin D status above deﬁcient levels may be
sufﬁcient(42,43).
Strengths and limitations
The strength of the AGES-Reykjavik Study lies in the exten-
sive data gathered in this population-based cohort allowing
for adjustments of potential confounders such as various life-
style behaviours and chronic diseases. Although there was a
high prevalence of elderly with deﬁcient (<30 nmol/l) serum
vitamin D levels, reﬂecting the advanced age and living condi-
tions (northern latitude), some of the cohort beneﬁted to some
degree by the traditional practice of ingesting cod liver oil on a
regular basis.
There are several limitations. The cross-sectional nature of
our study and the single measure of vitamin D status leaves
the possibility for reverse causality where older individuals
with a past history of depression may have changed their diet-
ary habits and this could be reﬂected in their serum vitamin D
status as measured by 25(OH)D concentration. However,
there is some evidence from a Norwegian study that vitamin
D status tracks longitudinally over time(44). In this cohort,
cod liver oil intake during midlife (40–50 years of age) col-
lected from the FFQ and which has been validated(22) was
strongly correlated with cod liver oil intake in late life, suggest-
ing that the frequency of use for this vitamin D-containing
supplement is indicative of long-term use. In addition, our
results indicated that there was minimal seasonal variation in
vitamin D levels, suggesting that the serum vitamin D levels
in this cohort are likely to reﬂect longstanding vitamin D sta-
tus. We do acknowledge that vitamin D intake and status can
be markers of a healthier lifestyle and the presence of depres-
sion or depressive symptoms may alter behaviours affecting
vitamin D status such as sun exposure. The lifetime prevalence
of major depressive disorder in Iceland is between 15 and 25
%, with a point prevalence of 3·8–4·8 %(45). The relatively
lower prevalence of current depression in this cohort and the
simultaneous frequent use of cod liver oil may limit the gener-
alisability of our results. We also acknowledge that the strength
of the association between vitamin D and GDS-15 scores, as
well as with major depressive disorder, is small and further
research in needed. Longitudinal assessment of both depres-
sion and vitamin D values would provide greater insight into
how these two measures are related and whether the temporal
relationship differs over time in men compared with women.
Conclusion
Our ﬁndings contribute to the growing evidence supporting the
association between vitamin D status and mental health. It is
important to note that the association between depression and
Table 4. Risk of current major depressive disorder by serum 25-hydroxyvitamin D (25(OH)D) level in men and women
(Odds ratios and 95 % confidence intervals)
25(OH)D (nmol/l)
Current major depressive
disorder (cases/n)
Model 1* Model 2† Model 3‡
OR 95 % CI OR 95 % CI OR 95 % CI
Men
Deficient (<30) 10/285 3·06 1·34, 6·95 2·56 1·05, 6·20 2·51 1·03, 6·13
Inadequate (30–49·9) 3/571 0·45 0·13, 1·58 0·44 0·12, 1·55 0·43 0·12, 1·54
Adequate (≥50) 15/1246 Reference Reference Reference
Women
Deficient (<30) 13/523 1·26 0·64, 2·47 0·83 0·40, 1·72 0·80 0·39, 1·66
Inadequate (30–49·9) 10/902 0·58 0·28, 1·21 0·46 0·22, 0·97 0·45 0·21, 1·00
Adequate (≥50) 27/1401 Reference Reference Reference
* Adjusted for age, season and education.
†Adjusted for age, season, education, BMI, smoking status, alcohol intake, partner status, multivitamin use and physical activity.
‡Adjusted for age, season, education, BMI, smoking status, alcohol intake, partner status, multivitamin use, physical activity, type 2 diabetes, CHD and hypertension.
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vitamin D in men was observed at a relatively low level of
serum 25(OH)D (<30 nmol/l). In northern latitudes, maintain-
ing vitamin D levels above 30 nmol/l may protect older adults
against adverse health conditions which are associated with
depression. Future research on the effects of vitamin D should
examine in-depth differences between men and women when
assessing the risk of depression among older adults.
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